UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone health in cancer patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2014-09, Vol.25 Suppl 3, p.iii124-iii137

2014

Volltextzugriff (PDF)

Bone health in cancer: ESMO Clinical Practice Guidelines

Annals of oncology, 2020-12, Vol.31 (12), p.1650-1663

2020

Volltextzugriff (PDF)

The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study

Osteoporosis international, 2021-02, Vol.32 (2), p.251-259

2021

Volltextzugriff (PDF)

The evolution of selective estrogen receptor modulators in osteoporosis therapy

Climacteric : the journal of the International Menopause Society, 2012-12, Vol.15 (6), p.513-523

Hadji, P.

2012

Volltextzugriff (PDF)

Bone health in estrogen-free contraception

Osteoporosis international, 2019-12, Vol.30 (12), p.2391-2400

2019

Volltextzugriff (PDF)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

Osteoporosis international, 2017-07, Vol.28 (7), p.2023-2034

2017

Volltextzugriff (PDF)

Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis

Osteoporosis international, 2021-11, Vol.32 (11), p.2383-2387

2021

Volltextzugriff (PDF)

The tamoxifen paradox—influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer

Osteoporosis international, 2018-11, Vol.29 (11), p.2557-2564

2018

Volltextzugriff (PDF)

Hormonersatztherapie und Prävention gemäß S3-Leitlinie

Gynäkologe (Berlin), 2020-12, Vol.53 (Suppl 2), p.161-166

2020

Volltextzugriff (PDF)

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

Osteoporosis international, 2017-03, Vol.28 (3), p.767-774

2017

Volltextzugriff (PDF)

Practical guidance for the management of aromatase inhibitor-associated bone loss

Annals of oncology, 2008-08, Vol.19 (8), p.1407-1416

2008

Volltextzugriff (PDF)

Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up

Osteoporosis international, 2018, Vol.29 (1), p.135-142

2018

Volltextzugriff (PDF)

Menopausal symptoms and adjuvant therapy-associated adverse events

Endocrine-related cancer, 2008-03, Vol.15 (1), p.73-90

Hadji, P

2008

Volltextzugriff (PDF)

Hormonersatztherapie und Prävention gemäß S3-Leitlinie

Gynäkologische Endokrinologie, 2020-02, Vol.18 (1), p.14-20

2020

Volltextzugriff (PDF)

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Annals of oncology, 2011-12, Vol.22 (12), p.2546-2555

2011

Volltextzugriff (PDF)

Pregnancy-associated osteoporosis: a case-control study

Osteoporosis international, 2017-04, Vol.28 (4), p.1393-1399

2017

Volltextzugriff (PDF)

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors

Annals of oncology, 2019-06, Vol.30 (6), p.908-920

2019

Volltextzugriff (PDF)

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Annals of oncology, 2008-03, Vol.19 (3), p.420-432

2008

Volltextzugriff (PDF)

Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom

Osteoporosis international, 2019-09, Vol.30 (9), p.1745-1754

2019

Volltextzugriff (PDF)

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

Annals of oncology, 2016-03, Vol.27 (3), p.379-390

2016

Volltextzugriff (PDF)

Oral contraceptive use and fracture risk—a retrospective study of 12,970 women in the UK

Osteoporosis international, 2017-08, Vol.28 (8), p.2349-2355

2017

Volltextzugriff (PDF)

The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK

Osteoporosis international, 2017, Vol.28 (1), p.291-297

2017

Volltextzugriff (PDF)

Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study

Annals of oncology, 2016-10, Vol.27 (10), p.1909-1915

2016

Volltextzugriff (PDF)

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Osteoporosis international, 2015-10, Vol.26 (10), p.2479-2489

2015

Volltextzugriff (PDF)

1 – 25 von 752

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(617)
Mit Volltextzugriff
(573)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Bone health in cancer patients: ESMO Clinical Practice Guidelines

Bone health in cancer: ESMO Clinical Practice Guidelines

The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study

The evolution of selective estrogen receptor modulators in osteoporosis therapy

Bone health in estrogen-free contraception

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis

The tamoxifen paradox—influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer

Hormonersatztherapie und Prävention gemäß S3-Leitlinie

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

Practical guidance for the management of aromatase inhibitor-associated bone loss

Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up

Menopausal symptoms and adjuvant therapy-associated adverse events

Hormonersatztherapie und Prävention gemäß S3-Leitlinie

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Pregnancy-associated osteoporosis: a case-control study

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

Oral contraceptive use and fracture risk—a retrospective study of 12,970 women in the UK

The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK

Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Suchergebnisse filtern